+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 17Years - 30Years
All Genders
ID07226895

Study of Twice-Daily MT1988 for 8 Weeks to Assess Changes in Cognitive, Clinical, Biological, and Digital Measures in Young Adults at High Risk for Psychosis

Led by Monument Therapeutics Limited · Updated on 2026-06-08

150

Participants Needed

15

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying people aged 17 to 30 who are at high risk of developing psychosis. The trial evaluates how different tests, called biomarkers, change when participants take the drug MT1988 twice daily for 8 weeks. The main goal is to see if any of these tests can detect changes caused by two different dose levels of MT1988 compared to a placebo. This will help develop ways to measure treatment effects in future studies for psychosis symptoms. Participants are randomly assigned to receive either a low dose or a high dose of MT1988, or a placebo, taken orally twice a day for 8 weeks. They visit the clinic every two weeks to undergo various assessments and report any side effects. The study uses a quadruple masking design, meaning that participants, caregivers, researchers, and analysts do not know who receives which treatment. During the trial, participants complete tests of memory, symptoms, cognition, neurophysiology, and behavior. These include computerized tests, questionnaires, blood and saliva samples for biological markers, and monitoring of physical activity and phone use through an app. The main outcomes focus on changes in verbal memory, positive and negative symptoms of psychosis after 8 weeks. Safety and tolerability are also closely monitored throughout the study period.

CONDITIONS

Brief Title

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

Research Team

S

Sheryl Caswell

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here